SOOIL LLC.

SOOIL Development Co., Ltd. is a leading South Korean medical device manufacturer specializing in insulin pump systems and diabetes management solutions. The company develops advanced insulin delivery devices including the Diabecare DANA-i and DANA IIS series, which provide precise subcutaneous insulin administration with integrated blood glucose monitoring capabilities. SOOIL also offers a mobile application for remote diabetes management and patient monitoring. The company combines cutting-edge medical technology with precision engineering to support patients with diabetes care, focusing on improving glycemic control and preventing complications through active insulin therapy. Products are FDA and CE-certified, and the company serves both B2B healthcare institutions and B2C patient markets globally.